Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 860 (ZNF860) is a member of the C2H2-type zinc finger protein family. These proteins contain finger-like motifs stabilized by zinc ions and primarily function as transcription factors, regulating gene expression by binding specific DNA sequences. ZNF860 is predicted to regulate transcription by interacting with cis-regulatory regions and RNA polymerase II, with activity localized in the nucleus[5][1][3]. While zinc finger proteins broadly are involved in diverse biological processes such as metabolism, apoptosis, and differentiation, no specific biological roles, disease associations, or drug interactions have been described for ZNF860 in available sources[5][1][2][3]. Summary: ZNF860 is a nuclear C2H2-type zinc finger transcription factor, active in gene regulation, with no reported drug interactions, mechanisms of action, disease roles, or safety concerns. It is not currently considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 860 (ZNF860).